Equities
Health CareMedical Equipment and Services
  • Price (DKK)100.40
  • Today's Change1.75 / 1.77%
  • Shares traded395.30k
  • 1 Year change-26.42%
  • Beta0.9365
Data delayed at least 15 minutes, as of Jul 02 2025 15:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The Company markets its products worldwide. The Company operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.

  • Revenue in DKK (TTM)5.83bn
  • Net income in DKK370.00m
  • Incorporated1956
  • Employees5.24k
  • Location
    Ambu A/SBaltorpbakken 13BALLERUP 2750DenmarkDNK
  • Phone+45 72252000
  • Fax+45 72252050
  • Websitehttps://www.ambu.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Elekta AB (publ)12.01bn158.05m12.06bn4.54k79.072.1311.761.000.62070.620747.1523.040.59673.733.053,972,002.000.79483.481.416.2137.8138.221.336.020.86345.270.461---0.56854.29-81.80-26.2215.56--
Vitrolife AB2.41bn332.10m12.76bn1.15k38.451.4620.345.303.673.6726.6396.910.21543.645.973,222,322.002.97-3.383.08-3.5259.3258.0613.80-17.403.088.140.1294--2.7619.51113.326.0318.32--
Embla Medical hf5.42bn456.11m14.52bn4.08k31.852.8717.772.681.071.0712.6511.810.54752.146.691,329,288.004.643.775.484.4263.1962.228.476.601.104.850.39730.008.814.4916.940.66884.25--
AddLife AB6.95bn206.06m14.74bn2.25k73.954.4719.652.122.542.5485.4941.990.81383.915.794,617,908.002.434.453.647.0037.5837.392.995.130.52523.010.48333.596.2124.2132.6312.3828.288.45
Ambu A/S5.83bn370.00m23.18bn5.24k71.284.4421.663.971.381.3821.8422.200.80612.177.201,122,787.005.113.225.883.8760.2759.546.344.431.6739.600.085725.4112.9013.8439.88-5.812.060.00
Asker Healthcare Group AB-66.69bn-66.69bn27.33bn3.57k----------------------------------------1.06--0.3635--11.69--77.34------
Getinge AB23.72bn986.30m32.09bn11.83k34.871.6913.251.355.435.43130.58112.170.61012.717.013,016,369.002.565.163.366.7947.5547.884.208.480.82917.570.271943.259.215.53-32.096.031.4225.12
Data as of Jul 02 2025. Currency figures normalised to Ambu A/S's reporting currency: Danish Krone DKK

Institutional shareholders

26.46%Per cent of shares held by top holders
HolderShares% Held
Schroder Investment Management Ltd.as of 31 Mar 202515.13m6.44%
Capital Research & Management Co. (World Investors)as of 31 Mar 20257.92m3.37%
Allianz Global Investors GmbHas of 28 Feb 20256.23m2.65%
The Vanguard Group, Inc.as of 04 Jun 20256.03m2.57%
Fundsmith LLPas of 31 Dec 20245.30m2.26%
Artisan Partners LPas of 31 Mar 20255.27m2.24%
Brown Capital Management LLCas of 31 Mar 20255.08m2.16%
Norges Bank Investment Managementas of 30 Jun 20244.48m1.91%
Capital International Ltd.as of 31 Mar 20253.72m1.58%
Baillie Gifford & Co.as of 30 May 20253.03m1.29%
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.